What began as an accidental discovery in a chemistry lab has evolved into a deeptech venture with the potential to significantly impact organoid research and regenerative medicine. 

XS Innovations is tackling a major challenge for people with end-stage kidney disease: keeping their blood vessel access open for dialysis. Most patients need a special connection between an artery and a vein in their arm, called an arteriovenous fistula (AVF), to ensure enough blood flows during treatment. 

Although the National Growth Fund has officially concluded following its third round of funding, several million euros remain available for promising new initiatives—especially in the field of Health & Care.